How to Finance a SaaS Roll-Up Without Dilution
Short answer. A roll-up multiplies the dilution problem. Fund ten acquisitions with equity and you can give away control of the company before the strategy pays off. The alternative is to buy with capital repaid from the combined cash flow: an acquisition or delayed-draw term loan for programmatic bolt-ons, revenue-based financing for smaller ones, and seller notes or earnouts to bridge price. Each deal is sized against combined recurring revenue and gated by the unit economics of the target.
Buy-and-build has become a default growth path in software, from private-equity platforms to founder-led serial acquirers. The strategy requires constant capital, but funding each deal with equity defeats the point of the roll-up, and the math turns on you fast.
Why equity is the wrong tool for serial acquisitions
Dilution compounds across a roll-up the way interest compounds against a borrower. Issue 8 percent of the company to buy your first target, another 7 for the second, 6 for the third, and you have parted with a fifth of the business after three deals, before the synergies that justify the roll-up have shown up. A platform running a dozen bolt-ons on equity can leave founders and early backers as minority holders in the company they built.
The deeper problem is timing. Equity pays the full price on day one, in the most expensive currency you have, for value that arrives over years. Debt matches the cost of the acquisition to the cash the acquisition produces. That is the entire case for funding a roll-up on the balance sheet rather than the cap table, and it is why disciplined serial acquirers treat equity as the capital of last resort, not first.
What non-dilutive instruments fund a roll-up?
A standard non-dilutive stack relies on four instruments, usually in combination. A delayed-draw term loan or acquisition line funds programmatic bolt-ons from a pre-approved facility. Revenue-based financing covers smaller, faster deals without a new credit process. Seller notes defer part of the price at a modest rate. Earnouts push contingent value to the future. None of them touch the cap table.
| Instrument | Best for | Typical cost | Dilution |
|---|---|---|---|
| Delayed-draw term loan / acquisition line | Programmatic bolt-ons from one facility | Roughly 11 to 14 percent all-in | None |
| Revenue-based financing | Smaller, fast deals | 1.1 to 1.5x repayment cap | None |
| Seller note (vendor take-back) | Bridging a price gap | 6 to 10 percent, often deferred | None |
| Earnout | Targets with uncertain growth | Contingent on performance | None |
The delayed-draw term loan is the workhorse. You negotiate one facility, then draw against it as targets close, which avoids running a fresh financing for every deal and gives sellers confidence you can actually pay. Revenue-based financing suits the small bolt-on that would not justify a full credit process, though its cost climbs the faster you repay, so read an RBF term sheet as an effective rate before leaning on it. Seller notes and earnouts do double duty, closing a valuation gap while spreading the cash out. The mechanics of blending them on a single deal sit in our guide to financing a SaaS acquisition without equity; a roll-up simply runs that playbook on repeat, with a facility built for the pattern.
How much can you borrow against each acquisition?
Lenders size acquisition debt against the combined recurring revenue and its quality, not the target alone. Expect advances in the range of 3 to 5 times combined ARR-linked cash flow for a healthy software platform, tightened by churn, gross margin, and how much debt already sits on the balance sheet. Each new draw is underwritten against the whole, so early discipline preserves capacity for later deals.
The number that governs your borrowing is not the purchase price but the combined recurring cash flow and how reliably it repays. A lender looks at the platform after the bolt-on: does blended net revenue retention hold, is gross margin intact, and does the combined entity still service its debt with room to spare. This is the same sizing question that governs any venture debt raise, applied to a moving target that grows with each deal. A platform at $20 million of combined ARR throwing off $6 million of cash flow might support $18 to $30 million of acquisition debt, enough for two or three mid-size bolt-ons before equity has to enter at all. Over-borrow on deal three and you cap what you can raise for deals four and five, which is how a promising roll-up stalls halfway through with the best targets still on the board.
The discipline that keeps a debt-funded roll-up alive
Debt scales risk as fast as it scales revenue. The roll-ups that fail rarely fail on any single acquisition; they fail because debt stacked up faster than integrated cash flow, and one soft quarter tripped a covenant across the whole facility. The discipline that prevents it is to underwrite each bolt-on on its own merits before it joins the platform, then to keep total borrowing inside a band the combined cash flow can carry through a downturn. Leave covenant headroom on purpose, because the point of a downturn is that it arrives when you did not plan for it.
That per-deal test is where unit economics earn their place. Treating each target's acquisition spend as capital, through the EBITCAC lens, tells you whether a bolt-on adds to the platform's debt capacity or quietly erodes it. A target with a stretched payback and thin margin does not just underperform; it consumes borrowing base the next deal needed. Pair the model with a clear view of the synergies you can actually bank, and the roll-up compounds value instead of debt. The same retention math that decides whether acquisition synergies are real also decides whether your lender keeps advancing.
Frequently asked questions
Can a roll-up really be funded entirely without equity?
Rarely all of it, but far more than most founders assume. A platform with healthy retention and margin can fund the bulk of a bolt-up program on a delayed-draw facility, seller notes, and earnouts, reserving equity for the occasional large or strategic deal where debt capacity runs short. The goal is not zero equity; it is not defaulting to equity for deals that debt can carry.
What kills most debt-funded roll-ups?
Debt outrunning integration. Buyers stack acquisitions faster than they combine the operations and cash flows behind them, so debt service climbs while the synergies meant to cover it lag. One weak quarter then trips a covenant across the entire facility. Slower, fully-integrated deals beat a fast stack that breaks.
Do seller notes count as non-dilutive financing?
Yes. A seller note is the seller lending part of the price back, repaid from the business over time, with no equity changing hands beyond the deal itself. It bridges a valuation gap and preserves cash at close, which is why it pairs naturally with an acquisition facility in a roll-up.
A roll-up is a financing strategy as much as an acquisition strategy. Buy with capital the combined business repays, size each deal against the whole, and keep borrowing inside what the cash flow can carry, and the equity you set out to protect stays yours. If you want to see how a bolt-on program could be funded against the recurring revenue it builds, check your CVF compatibility.
